Injection, Suspension · Intramuscular
Influenza A Virus A/Georgia/12/2022 Cvr-167 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/Victoria/800/2024 Cvr-289 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Singapore/Wuh4618/2021 Antigen (Mdck Cell Derived, Propiolactone Inactivated)
Brands: Flucelvax · Influenza A Virus A/Georgia/12/2022 Cvr-167 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated) + Influenza A Virus A/Victoria/800/2024 Cvr-289 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated) + Influenza B Virus B/Singapore/Wuh4618/2021 Antigen (Mdck Cell Derived, Propiolactone Inactivated)
1 ACTIVE SUPPLIER - US
openFDA · updated weekly
US2 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComingsoon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bamboo US BidCo LLC | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.